Ligand Pharmaceuticals ROE 2006-2019 | LGND

Current and historical return on equity (ROE) values for Ligand Pharmaceuticals (LGND) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Ligand Pharmaceuticals ROE for the three months ending September 30, 2019 was 7.47%.
Ligand Pharmaceuticals ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-09-30 $0.60B $0.85B 67.36%
2019-06-30 $0.68B $1.04B 80.07%
2019-03-31 $0.76B $1.08B 103.21%
2018-12-31 $0.14B $0.56B 24.22%
2018-09-30 $0.18B $0.70B 32.35%
2018-06-30 $0.12B $0.62B 25.00%
2018-03-31 $0.05B $0.48B 12.46%
2017-12-31 $0.01B $0.40B 3.08%
2017-09-30 $0.02B $0.40B 4.26%
2017-06-30 $0.01B $0.39B 2.51%
2017-03-31 $-0.00B $0.37B -0.87%
2016-12-31 $-0.00B $0.34B -0.29%
2016-09-30 $0.01B $0.34B 2.52%
2016-06-30 $0.21B $0.33B 67.32%
2016-03-31 $0.24B $0.37B 98.03%
2015-12-31 $0.23B $0.24B 146.03%
2015-09-30 $0.23B $0.29B 221.58%
2015-06-30 $0.03B $0.07B 78.57%
2015-03-31 $0.01B $0.03B 27.16%
2014-12-31 $0.01B $0.02B 24.62%
2014-09-30 $0.01B $0.04B 12.67%
2014-06-30 $0.01B $0.06B 14.35%
2014-03-31 $0.01B $0.07B 24.12%
2013-12-31 $0.01B $0.05B 26.67%
2013-09-30 $0.01B $0.05B 28.37%
2013-06-30 $0.01B $0.04B 27.35%
2013-03-31 $-0.00B $0.03B -4.21%
2012-12-31 $-0.00B $0.03B -4.82%
2012-09-30 $0.00B $0.02B 18.46%
2012-06-30 $-0.00B $0.02B -8.70%
2012-03-31 $0.00B $0.02B 23.53%
2011-12-31 $0.01B $0.01B 220.00%
2011-09-30 $0.01B $0.00B 628.57%
2011-06-30 $0.00B $0.01B -300.00%
2011-03-31 $0.00B $0.01B -200.00%
2010-12-31 $-0.01B $-0.01B 444.44%
2010-09-30 $-0.01B $-0.01B -2767011611056432640.00%
2010-06-30 $0.00B $0.00B 922337203685477632.00%
2010-03-31 $0.00B $0.00B 0.00%
2009-12-31 $-0.00B $0.00B 25.00%
2009-09-30 $-0.08B $-0.01B 652.17%
2009-06-30 $-0.10B $-0.01B 1085.71%
2009-03-31 $-0.10B $-0.02B 9900.00%
2008-12-31 $-0.10B $-0.01B -1088.89%
2008-09-30 $-0.02B $0.00B -117.33%
2008-06-30 $-0.00B $0.02B -12.12%
2008-03-31 $0.00B $0.03B 10.53%
2007-12-31 $0.28B $0.03B 769.86%
2007-09-30 $0.42B $0.03B 1155.56%
2007-06-30 $0.40B $0.03B -1203.01%
2007-03-31 $0.38B $0.06B -378.33%
2006-12-31 $-0.03B $0.03B 18.63%
2006-09-30 $-0.18B $-0.25B 85.44%
2006-06-30 $-0.17B $-0.24B 98.09%
2006-03-31 $-0.16B $-0.22B 117.65%
2005-12-31 $-0.04B $-0.11B 34.78%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.602B $0.251B
Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $143.614B 16.54
CSL (CSLLY) Australia $93.536B 0.00
Gilead Sciences (GILD) United States $81.096B 10.05
Vertex Pharmaceuticals (VRTX) United States $60.212B 61.46
Biogen (BIIB) United States $52.886B 9.08
Illumina (ILMN) United States $47.097B 51.68
Regeneron Pharmaceuticals (REGN) United States $42.902B 18.79
Alexion Pharmaceuticals (ALXN) United States $24.902B 12.30
Seattle Genetics (SGEN) United States $18.278B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.372B 0.00
Incyte (INCY) United States $17.348B 40.27
BioMarin Pharmaceutical (BMRN) United States $15.963B 0.00
Genmab (GNMSF) Denmark $14.195B 62.70
Alnylam Pharmaceuticals (ALNY) United States $13.166B 0.00
Galapagos (GLPG) Belgium $11.944B 30.77
Exact Sciences (EXAS) United States $11.645B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.484B 55.12
BeiGene (BGNE) Cayman Islands $10.078B 0.00
Sarepta Therapeutics (SRPT) United States $9.709B 0.00
Bio-Techne Corp (TECH) United States $8.396B 56.20
BioNTech SE (BNTX) Germany $7.817B 0.00
QIAGEN (QGEN) Netherlands $7.661B 24.98
Guardant Health (GH) United States $7.568B 0.00
Horizon Therapeutics Public (HZNP) Ireland $7.069B 17.97
ACADIA Pharmaceuticals (ACAD) United States $6.993B 0.00
Amarin (AMRN) Ireland $6.930B 0.00
Moderna (MRNA) United States $6.745B 0.00
Reata Pharmaceuticals (RETA) United States $6.431B 0.00
Exelixis (EXEL) United States $6.197B 17.43
Ascendis Pharma (ASND) Denmark $5.865B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.816B 0.00
Bluebird Bio (BLUE) United States $5.186B 0.00
Repligen (RGEN) United States $5.185B 93.96
China Biologic Products (CBPO) China $4.609B 25.97
MorphoSys AG (MOR) Germany $4.179B 0.00
Blueprint Medicines (BPMC) United States $3.949B 0.00
Mirati Therapeutics (MRTX) United States $3.866B 0.00
Immunomedics (IMMU) United States $3.784B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.694B 0.00
Adaptive Biotechnologies (ADPT) United States $3.682B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.523B 0.00
MyoKardia (MYOK) United States $3.517B 0.00
NeoGenomics (NEO) United States $3.382B 179.97
CRISPR Therapeutics AG (CRSP) Switzerland $3.288B 0.00
Alkermes (ALKS) Ireland $3.150B 0.00
UniQure (QURE) Netherlands $3.034B 0.00
Zai Lab (ZLAB) China $3.006B 0.00
Genmab (GMAB) Denmark $2.971B 6.12
Halozyme Therapeutics (HALO) United States $2.965B 0.00
Acceleron Pharma (XLRN) United States $2.884B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.862B 0.00
Emergent Biosolutions (EBS) United States $2.837B 28.18
Amicus Therapeutics (FOLD) United States $2.647B 0.00
Epizyme (EPZM) United States $2.382B 0.00
Arena Pharmaceuticals (ARNA) United States $2.264B 5.27
RA PHARMCTL INC (RARX) United States $2.216B 0.00
Myriad Genetics (MYGN) United States $2.183B 32.25
Insmed (INSM) United States $2.134B 0.00
Denali Therapeutics (DNLI) United States $1.977B 0.00
Fate Therapeutics (FATE) United States $1.850B 0.00
Principia Biopharma (PRNB) United States $1.811B 0.00
REGENXBIO (RGNX) United States $1.752B 0.00
Arvinas (ARVN) United States $1.742B 0.00
Zymeworks (ZYME) Canada $1.732B 0.00
Akcea Therapeutics (AKCA) United States $1.717B 0.00
Editas Medicine (EDIT) United States $1.682B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.482B 0.00
Intra-Cellular Therapies (ITCI) United States $1.460B 0.00
Innoviva (INVA) United States $1.458B 4.30
Dicerna Pharmaceuticals (DRNA) United States $1.395B 0.00
Coherus BioSciences (CHRS) United States $1.389B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.352B 0.00
Alector (ALEC) United States $1.303B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Athenex (ATNX) United States $1.195B 0.00
DBV Technologies S.A (DBVT) France $1.166B 0.00
Zealand Pharma (ZEAL) Denmark $1.148B 0.00
Codexis (CDXS) United States $1.083B 0.00
Revance Therapeutics (RVNC) United States $1.033B 0.00
PHARMA MAR SA (PHMMF) Spain $1.025B 0.00
Sangamo Therapeutics (SGMO) United States $1.019B 0.00
Pharming Group (PHGUF) Netherlands $0.955B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.897B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.879B 0.00
Mesoblast (MESO) Australia $0.832B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.807B 6.78
Cellectis S.A (CLLS) France $0.785B 0.00
Twist Bioscience (TWST) United States $0.782B 0.00
GENFIT S.A (GNFT) France $0.775B 0.00
Heska (HSKA) United States $0.767B 195.98
Vericel (VCEL) United States $0.760B 283.33
Cytokineticsorporated (CYTK) United States $0.749B 0.00
Sorrento Therapeutics (SRNE) United States $0.732B 0.00
Adverum Biotechnologies (ADVM) United States $0.732B 0.00
Intellia Therapeutics (NTLA) United States $0.725B 0.00
ANI Pharmaceuticals (ANIP) United States $0.720B 12.28
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.713B 0.00
Retrophin (RTRX) United States $0.703B 0.00
Anika Therapeutics (ANIK) United States $0.682B 22.12
UROGEN PHARMA (URGN) United States $0.679B 0.00
Cara Therapeutics (CARA) United States $0.672B 0.00
AC Immune SA (ACIU) Switzerland $0.668B 15.45
Prothena (PRTA) Ireland $0.608B 0.00
Precision BioSciences (DTIL) United States $0.591B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.588B 0.00
Kadmon Holdings (KDMN) United States $0.558B 0.00
BioDelivery Sciences (BDSI) United States $0.522B 0.00
NantKwest (NK) United States $0.521B 0.00
Clovis Oncology (CLVS) United States $0.517B 0.00
Agenus (AGEN) United States $0.511B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.511B 0.00
Dynavax Technologies (DVAX) United States $0.481B 0.00
Bellus Health (BLU) Canada $0.480B 0.00
Arcus Biosciences (RCUS) United States $0.475B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.470B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.465B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.453B 3.13
Xenon Pharmaceuticals (XENE) Canada $0.438B 0.00
Pfenex (PFNX) United States $0.433B 0.00
AnaptysBio (ANAB) United States $0.421B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.420B 0.00
Kindred Biosciences (KIN) United States $0.406B 0.00
Gritstone Oncology (GRTS) United States $0.405B 0.00
Syros Pharmaceuticals (SYRS) United States $0.390B 0.00
PDL BioPharma (PDLI) United States $0.379B 9.49
Avid Bioservices (CDMO) United States $0.368B 0.00
Merus (MRUS) Netherlands $0.365B 0.00
Cue Biopharma (CUE) United States $0.365B 0.00
CytomX Therapeutics (CTMX) United States $0.355B 0.00
POXEL SA FRANCE (PXXLF) France $0.350B 0.00
Stemline Therapeutics (STML) United States $0.343B 0.00
Cellular Biomedicine (CBMG) United States $0.337B 0.00
Inovio Pharmaceuticals (INO) United States $0.335B 0.00
Cel-Sci (CVM) United States $0.328B 0.00
Puma Biotechnology (PBYI) United States $0.326B 0.00
Albireo Pharma (ALBO) United States $0.325B 0.00
VBI Vaccines (VBIV) United States $0.324B 0.00
Starpharma Holdings (SPHRY) Australia $0.314B 0.00
MannKind (MNKD) United States $0.314B 0.00
Geron (GERN) United States $0.298B 0.00
Compugen (CGEN) Israel $0.297B 0.00
Mersana Therapeutics (MRSN) United States $0.295B 0.00
IVERIC Bio (ISEE) United States $0.284B 0.00
WAVE Life Sciences (WVE) Singapore $0.273B 0.00
Sutro Biopharma (STRO) United States $0.272B 0.00
Prometic Life Sciences (LMNL) Canada $0.266B 0.00
ADMA Biologics Inc (ADMA) United States $0.261B 0.00
ChromaDex (CDXC) United States $0.261B 0.00
Kamada (KMDA) Israel $0.260B 7.60
OSMOTICA PHARM (OSMT) United States $0.257B 0.00
Biofrontera AG (BFRA) Germany $0.255B 0.00
Theratechnologies (THTX) Canada $0.235B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.235B 0.00
Seres Therapeutics (MCRB) United States $0.229B 0.00
Exicure (XCUR) United States $0.227B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.219B 0.00
Affimed (AFMD) Germany $0.217B 0.00
Cerecor (CERC) United States $0.216B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.215B 0.00
XOMA (XOMA) United States $0.210B 0.00
Athersys (ATHX) United States $0.204B 0.00
ARAVIVE, INC (ARAV) United States $0.198B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.195B 0.00
Protagonist Therapeutics (PTGX) United States $0.195B 0.00
Arbutus Biopharma (ABUS) Canada $0.191B 0.00
Alcobra (ARCT) United States $0.184B 0.00
Five Prime Therapeutics (FPRX) United States $0.181B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.179B 0.00
CorMedix Inc (CRMD) United States $0.178B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.176B 0.00
Spero Therapeutics (SPRO) United States $0.175B 0.00
Menlo Therapeutics (MNLO) United States $0.169B 0.00
Fortress Biotech (FBIO) United States $0.168B 0.00
TELA Bio (TELA) United States $0.167B 0.00
Palatin Technologies (PTN) United States $0.164B 4.46
Dyadic (DYAI) United States $0.153B 0.00
Verastem (VSTM) United States $0.152B 0.00
PHASEBIO PHARMA (PHAS) United States $0.152B 0.00
Applied Genetic Technologies (AGTC) United States $0.149B 0.00
Windtree Therapeutics (WINT) United States $0.145B 0.00
Selecta Biosciences (SELB) United States $0.142B 0.00
Novavax (NVAX) United States $0.141B 0.00
Abeona Therapeutics (ABEO) United States $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Northwest Biotherapeutics (NWBO) United States $0.128B 0.00
Strongbridge Biopharma (SBBP) United States $0.125B 3.33
Arsanis (XFOR) United States $0.124B 0.00
VTv Therapeutics (VTVT) United States $0.123B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.123B 0.00
Enzo Biochem (ENZ) United States $0.122B 0.00
Aptinyx (APTX) United States $0.119B 0.00
Celyad SA (CYAD) Belgium $0.112B 0.00
Liquidia Technologies (LQDA) United States $0.111B 0.00
BioTime (LCTX) United States $0.110B 5.65
OvaScience (MLND) United States $0.108B 0.00
Clearside Biomedical (CLSD) United States $0.107B 0.00
Antibe Therapeutics (ATBPF) Canada $0.106B 0.00
SESEN BIO, INC (SESN) United States $0.104B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.103B 0.00
Acorda Therapeutics (ACOR) United States $0.102B 0.00
Synlogic (SYBX) United States $0.102B 0.00
Aduro Biotech (ADRO) United States $0.100B 0.00
Proteostasis Therapeutics (PTI) United States $0.096B 0.00
Emmaus Life Sciences (EMMA) United States $0.091B 0.00
AIT Therapeutics (XAIR) United States $0.089B 0.00
Catalyst Biosciences (CBIO) United States $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
Trevena (TRVN) United States $0.082B 0.00
Prima BioMed (IMMP) Australia $0.080B 0.00
Orgenesis (ORGS) United States $0.080B 5.18
Catabasis Pharmaceuticals (CATB) United States $0.080B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
NewLink Genetics (NLNK) United States $0.074B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.069B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.068B 0.00
Checkpoint Therapeutics (CKPT) United States $0.065B 0.00
Pluristem Therapeutics (PSTI) Israel $0.064B 0.00
Organovo Holdings (ONVO) United States $0.061B 0.00
Curis (CRIS) United States $0.056B 0.00
Idera Pharmaceuticals (IDRA) United States $0.055B 0.00
Protalix BioTherapeutics (PLX) Israel $0.054B 0.00
AquaBounty Technologies (AQB) United States $0.052B 0.00
DiaMedica Therapeutics (DMAC) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.050B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.050B 0.00
Evogene (EVGN) Israel $0.045B 0.00
Celldex Therapeutics (CLDX) United States $0.040B 0.00
CollPlant Holdings (CLGN) Israel $0.039B 0.00
BioCardia (BCDA) United States $0.037B 0.00
Soligenix (SNGX) United States $0.037B 0.00
Celsion (CLSN) United States $0.037B 0.00
Alimera Sciences (ALIM) United States $0.035B 0.00
Entera Bio (ENTX) Israel $0.032B 0.00
Bionano Genomics (BNGO) United States $0.031B 0.00
Pulmatrix (PULM) United States $0.030B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
VistaGen Therapeutics (VTGN) United States $0.030B 0.00
VIVUS (VVUS) United States $0.029B 0.00
AmpliPhi Biosciences (ARMP) United States $0.029B 0.00
Unum Therapeutics (UMRX) United States $0.029B 0.00
Novogen (KZIA) Australia $0.028B 0.00
Stellar Biotechnologies (EDSA) Canada $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.025B 0.00
Oncobiologics (OTLK) United States $0.024B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.020B 0.00
Advaxis (ADXS) United States $0.020B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.016B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
Cesca Therapeutics (THMO) United States $0.013B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Cleveland BioLabs (CBLI) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
IBio (IBIO) United States $0.007B 0.00
BioPharmX (BPMX) United States $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.005B 0.00